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   AIMS 
  RESULTS               
 The mean TNNN was 14.9 ± 1.9 billions in MS and 24.4 ± 2.4 billions in controls (p= 0.007) (C). 
 pwMS showed a 63% smaller number of neocortical neurons (p < 0.0001). This figure applied to all 
four cortical regions examined (p = 0.719). 
 In pwMS cortical volume was reduced by 50% (p < 0.0001), which was very similar in all four 
cortical regions analyzed. 
 The mean neuronal density [neurons/mm3] in pwMS was 57468 ± 3636 and in controls 79787 ± 
3869 indicating a similar reduction in all cortical regions of 28% (p < 0.0001) (D). 
 Neuronal density in MS was decreased by 20% in men (p < 0.0001) and by 26% in women (p < 
0.0001) compared to controls.  Neuronal density was significantly smaller in women compared to 
men, in MS by 19% (p < 0.0001) and in controls by 12% (p < 0.0001). 
 The mean proportion of demyelinated cortex was 41 ± 14 %. There was no evidence that 
demyelination varied by gender (p = 0.99), age (p = 0.794) or disease duration (p = 0.2). Frontal 
cortex was significantly more affected by demyelination than all other cortical regions (motor, p = 
0.004; parietal/temporal, p = 0.017; occipital, p < 0.0001). 
 Across the entire MS neocortex the extent of demyelination and the decrease in neuronal density 
were not linked (p = 0.21) (E). This lack of correlation was confirmed in a region-specific analysis (p 
= 0.322), including adjustment for gender (p = 0.118), age (p = 0.56) and disease duration (p = 
0.963). 
 The correlation between number of neurons and cortical volume was different in pwMS and 
controls (p < 0.0001). pwMS showed a smaller and shallower regression line (49787/mm3) than 
controls (68848/mm3) reflecting their lower neuronal density in the cortex (F, G). 
 All results are adjusted for cortical region, age at death, disease duration and gender. 
 Formalin fixed brain hemispheres of nine 
pwMS (6 F, 3 M, age = 68 ± 14, disease 
duration = 27 ± 5 years) and seven reference 
cases (4 M, 3 F, age= 75 ± 18 years) with no 
known neurological disease were studied. 
 Lobar topography of motor and occipital 
corteces was marked before dissection into 
1.1 cm-thick coronal slabs. 
 Slabs were embedded for processing in 
paraffin and sections stained for 
Giemsa/40μm (A) and myelin basic protein 
(MBP)/10μm (B).  
 Neurons were identified on Giemsa-stained 
sections using a microscope equipped with a 
stage controlled by Stereo Investigator. Areas 
of interest (AOI) were outlined to include the 
entire cortex on each section (A, blue); 
disectors were placed using systematic 
random sampling.  
 The total number of neocortical neurons 
(TNNN) was calculated as the sum of NV x VREF 
in each slab, where NV= neurons 
counted/volume of disectors quantified and 
VREF(cortical volume)= AOI x slab thickness (T), 
multiplied by 2.  
 Demyelination extent in the cortex was 
manually outlined on MBP images (B, red). 
 The loss of cortical neurons is a likely 
contributor to the progressive physical  and 
cognitive impairment of people with MS 
(pwMS). 
 There is variation of the reported degree of 
neuronal loss in the cortex, and the 
topographic distribution of this loss over the 
entire cortex is unknown.  
 Brain volume measures including cortical 
volume loss are used as MRI biomarkers of 
disease deterioration. However, the 
histological correlates of these indices are 
only partially known. 
 To quantify the total number of cortical 
neurons in MS vs controls in post mortem 
brain. 
 To explore the relationship between neuronal 
loss,  cortical volume and demyelination. 
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 To our knowledge, this was the first study estimating the extent of neuronal loss across the entire MS cortex using unbiased sampling techniques.  The TNNN we obtained in 
control cases was similar to previously reported figures [1] indicating robust methodology.  
 In our cohort of MS cases TNNN were more than halved while the overall neuronal density was reduced of about a third. 
 This severe neuronal loss was not linked to the extent cortical demyelination. However, it was strongly correlated with volume as expected using stereology derived 
measuring methods. This observation is indicating volume reduction, which in our MS cohort was also halved, as the closest measure to predict neuronal loss over time.     
 We are currently validating our measure of cortical volume with MRI measures on the same cohort of cases and assess whether cortical demyelination is spatially associated 
atrophy in isolated GM lesions. 
